POSTERS

NetraAI: Understanding Patient Populations Beyond Disease Labels for De-Risking Clinical Trials with Large Language Models

Uncovering an Association Between Oligodendroglioma and the Human Papillomavirus (HPV) Through Molecular Subpopulation Analysis Using NetraAI

Understanding treatment response in pancreatic cancer: NetraAI provides genetic differentiation in FOLFIRINOX and Gemcitabine response

Using AI on Data from Anxiety and Schizophrenia Trials to Identify Causal Clusters of Variables for Drug & Placebo Response Via Long Range Memory to Improve Clinical Trial Outcomes

Using NetraAI Hypothesis-Generation for Patient Stratification and Target Discovery in ALS
